Intuniv (guanfacine): Clinical Effectiveness

Hello and welcome to "VideoScript", presented by Drugs.com.

Today in the second of three presentations, we continue reviewing Intuniv, also known as guanfacine. Intuniv is an FDA-approved medication used as part of a treatment program to help manage the symptoms of ADHD in children.

Intuniv is in a class of medications known as selective alpha-2a adrenergic agonists.

Intuniv is not a stimulant medication or a controlled substance, and how it works in ADHD is not fully known.

In clinical trials, Intuniv has been shown to be superior to a placebo, or sugar pill, when evaluating treatment effect on the core symptoms of ADHD.

A 44% improvement in ADHD scores was seen in the Intuniv group compared to a 23% improvement in the placebo group.

Parents also reported significant improvements in their child’s ADHD symptoms.

Clinical trials show that Intuniv can be used with a stimulant, such as long-acting methylphenidate, if the stimulant alone is not sufficient for ADHD treatment.

Also, Intuniv can be given once a day, which may offer an advantage in school-aged children.

Thank you for joining us at Drugs.com for a brief review of Intuniv. Please refer to our patient and professional information, drug interaction checker, and additional tools on Drugs.com.

Patients with a concern about the use of Intuniv should consult with their health care provider.

Visit drugs.com/Intuniv for more information